Literature DB >> 15892144

Osteoblast interactions with calcium phosphate ceramics modified by coating with type I collagen.

J C Brodie1, E Goldie, G Connel, J Merry, M H Grant.   

Abstract

Complications associated with the use of autogenous bone in the repair or replacement of tissue lost through injury or disease have driven the search for alternative sources of graft material. Bioceramics containing hydroxyapatite (HA), tricalcium phosphate (TCP), or composites that combine the best properties of both of these materials are among the principal candidates. In this study, we have investigated the in vitro proliferation, morphology, and viability of an immortalized rat osteoblast cell line cultured on HA, TCP, and composites of the two in the ratios 75:25 (H75), 50:50 (H50), and 25:75 (H25) for 28 days. The biocompatibility of each material was examined in the presence and absence of a collagen coating. With the exception of H50, cell proliferation, quantified by carboxyfluorescein fluorescence, was enhanced by collagen coating of all materials for the first 14 days, although at later time points cell numbers were unaffected. It is notable that the collagen coating was least stable on H50, the only material not to show enhancement of cell growth on coating. Confocal laser scanning microscopy confirmed that cell growth was more extensive on coated materials over the first 7-14 days in culture, and the development of cell extensions and bridges across the pores in the materials was observed. Results indicate that collagen coating of calcium phosphate ceramics may also increase their compatibility and osseointegration in vivo. (c) 2005 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15892144     DOI: 10.1002/jbm.a.30279

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  17 in total

Review 1.  Scaffolding in tissue engineering: general approaches and tissue-specific considerations.

Authors:  B P Chan; K W Leong
Journal:  Eur Spine J       Date:  2008-11-13       Impact factor: 3.134

2.  Biologic Potential of Calcium Phosphate Biopowders Produced via Decomposition Combustion Synthesis.

Authors:  N Vollmer; K B King; R Ayers
Journal:  Ceram Int       Date:  2015-07-01       Impact factor: 4.527

Review 3.  Biocomposites and hybrid biomaterials based on calcium orthophosphates.

Authors:  Sergey V Dorozhkin
Journal:  Biomatter       Date:  2011 Jul-Sep

Review 4.  Scaffold design for bone regeneration.

Authors:  Liliana Polo-Corrales; Magda Latorre-Esteves; Jaime E Ramirez-Vick
Journal:  J Nanosci Nanotechnol       Date:  2014-01

5.  Biopolymer nanofibrils: structure, modeling, preparation, and applications.

Authors:  Shengjie Ling; Wenshuai Chen; Yimin Fan; Ke Zheng; Kai Jin; Haipeng Yu; Markus J Buehler; David L Kaplan
Journal:  Prog Polym Sci       Date:  2018-06-23       Impact factor: 29.190

6.  Collagen-calcium phosphate cement scaffolds seeded with umbilical cord stem cells for bone tissue engineering.

Authors:  WahWah Thein-Han; Hockin H K Xu
Journal:  Tissue Eng Part A       Date:  2011-08-18       Impact factor: 3.845

7.  The mechanical properties of calcium phospate ceramics modified by collagen coating and populated by osteoblasts.

Authors:  J C Brodie; J Merry; M H Grant
Journal:  J Mater Sci Mater Med       Date:  2006-01       Impact factor: 3.896

8.  Self-setting collagen-calcium phosphate bone cement: mechanical and cellular properties.

Authors:  Jennifer L Moreau; Michael D Weir; Hockin H K Xu
Journal:  J Biomed Mater Res A       Date:  2009-11       Impact factor: 4.396

Review 9.  Calcium Orthophosphate-Containing Biocomposites and Hybrid Biomaterials for Biomedical Applications.

Authors:  Sergey V Dorozhkin
Journal:  J Funct Biomater       Date:  2015-08-07

10.  Evaluation of collagen/heparin coated TCP/HA granules for long-term delivery of BMP-2.

Authors:  Gerjon Hannink; Paul J Geutjes; Willeke F Daamen; Pieter Buma
Journal:  J Mater Sci Mater Med       Date:  2012-11-08       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.